Classification Performance of the Ages and Stages Questionnaire: Influence of Maternal Education Level.
assessment
maternal instruction
neurodevelopment
prematurity
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
25 Feb 2023
25 Feb 2023
Historique:
received:
05
01
2023
revised:
18
02
2023
accepted:
22
02
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
(1) Background: The Ages and Stages Questionnaire-Third Edition (ASQ-3) is a parental screening questionnaire increasingly being used to evaluate the development of preterm children. We aimed to assess the classification performance of the ASQ-3 in preterm infant follow-up. (2) Methods: In this cross-sectional study, we included 185 children from the SEVE longitudinal cohort born <33 weeks of gestational age between November 2011 and January 2018, who had both an ASQ-3 score at 24 months of corrected age (CA) and a revised Brunet-Lézine (RBL) scale score at 30 months of CA. The ASQ-3 overall score and sub-scores were compared to the RBL developmental quotient (DQ) scores domain by domain. The diagnostic performance of the ASQ-3 was evaluated with the RBL as the reference method by calculating sensitivity, specificity, and positive and negative likelihood ratios. A multivariate analysis assessed the association between low maternal education level and incorrect evaluation with the ASQ-3. (3) Results: The ASQ-3 overall score had a specificity of 91%, a sensitivity of 34%, a positive likelihood ratio of 3.82, and a negative likelihood ratio of 0.72. Low maternal education level was a major risk factor for incorrectly evaluating children with the ASQ-3 (odds ratio 4.16, 95% confidence interval 1.47-12.03;
Identifiants
pubmed: 36980009
pii: children10030449
doi: 10.3390/children10030449
pmc: PMC10047153
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Front Pediatr. 2022 Dec 05;10:1004785
pubmed: 36545662
Rev Paul Pediatr. 2017 Apr-Jun;35(2):144-150
pubmed: 28977332
BMJ. 2021 Apr 28;373:n741
pubmed: 33910920
Eur J Paediatr Neurol. 2017 Mar;21(2):272-279
pubmed: 27889381
Pediatr Res. 2020 Oct;88(4):642-652
pubmed: 32050254
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
JAMA. 2017 Apr 4;317(13):1329-1337
pubmed: 28384828
Early Hum Dev. 2020 Feb;141:104933
pubmed: 31775095
Arch Dis Child. 2019 Apr;104(4):333-339
pubmed: 29960997
Eur J Paediatr Neurol. 2020 Sep;28:126-132
pubmed: 32758415
Cochrane Database Syst Rev. 2015 Nov 24;(11):CD005495
pubmed: 26597166
Dev Med Child Neurol. 2017 May;59(5):484-489
pubmed: 27882544
Dev Med Child Neurol. 2013 Nov;55 Suppl 4:1-4
pubmed: 24237270
Early Hum Dev. 2006 Mar;82(3):157-66
pubmed: 16530359
Early Hum Dev. 2015 Mar;91(3):217-25
pubmed: 25703316
BMJ. 2017 Aug 16;358:j3448
pubmed: 28814566
Child Dev. 2017 Jan;88(1):282-298
pubmed: 27364183
Dev Med Child Neurol. 2020 Dec;62(12):1450-1451
pubmed: 32654128
Cerebrovasc Dis. 2013;36(4):267-72
pubmed: 24135733
Pediatrics. 2012 Jul;130(1):e108-14
pubmed: 22689873
J Perinatol. 2011 Oct;31(10):641-6
pubmed: 21311498
Phys Occup Ther Pediatr. 2012 Aug;32(3):260-71
pubmed: 21859395
Pediatr Res. 2020 Jan;87(2):391-398
pubmed: 31666689
JAMA Pediatr. 2022 Oct 1;176(10):980-989
pubmed: 36036913
Dev Med Child Neurol. 2015 Apr;57 Suppl 2:4-9
pubmed: 25690109
Child Care Health Dev. 2010 Jul;36(4):485-90
pubmed: 20030657
PLoS One. 2011;6(5):e20004
pubmed: 21637833
Dev Med Child Neurol. 2010 Mar;52(3):232-7
pubmed: 20002114